Crea il mio profilo
Accesso pubblico
Visualizza tutto12 articoli
1 articolo
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Brad H NelsonDirector, Deeley Research Centre, BC Cancer AgencyEmail verificata su bccancer.bc.ca
- Robert A. HoltHead of Sequencing, Michael Smith Genome Sciences Centre, BC Cancer Agency Distinguished ScientistEmail verificata su bcgsc.ca
- Darin A. WickDeeley Research Centre, BC Cancer AgencEmail verificata su wick.ca
- Katey SS EnfieldFrancis Crick Institute, London, UKEmail verificata su crick.ac.uk
- Wan L. LamBC Cancer Research Centre; University of British ColumbiaEmail verificata su bccrc.ca
- Julie S. NielsenLeader, Cell Manufacturing, BC Cancer's Immunotherapy ProgramEmail verificata su bccancer.bc.ca
- Scott Derek BrownResearch Associate, BC Cancer Research InstituteEmail verificata su bcgsc.ca
- john webbBritish Columbia Cancer Agency / Deeley Research CentreEmail verificata su bccrc.ca
- Erin A Marshall, PhDUniversity of British Columbia (BC Cancer Research Centre)Email verificata su bccrc.ca
- Peter H WatsonBC CancerEmail verificata su bccancer.bc.ca
- Kwame Twumasi-BoatengTelix PharmaceuticalsEmail verificata su telixpharma.com
- David KroegerAssociate Director BD, Zymeworks Inc.Email verificata su usask.ca
- RL WarrenGenome Sciences Centre, BC CancerEmail verificata su bcgsc.ca
- Nathaniel R WestGenentechEmail verificata su gene.com
- Mauro CastellarinResearch Associate, University of Pennsylvania, Center for Cellular ImmunotherapiesEmail verificata su pennmedicine.upenn.edu
- George CoukosUniversity Hospital of Lausanne, Ludwig Institute for Cancer ResearchEmail verificata su chuv.ch
- Ewan A GibbIndependent Researcher
Segui
Spencer D. Martin, MD PhD
Faculty of Medicine, University of British columbia
Email verificata su vch.ca